OPERA LTD-ADR (OPRA) Fundamental Analysis & Valuation

NASDAQ:OPRAUS68373M1071

Current stock price

14.96 USD
+0.34 (+2.33%)
At close:
14.96 USD
0 (0%)
After Hours:

This OPRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. OPRA Profitability Analysis

1.1 Basic Checks

  • In the past year OPRA was profitable.
  • In the past year OPRA had a positive cash flow from operations.
  • Of the past 5 years OPRA 4 years were profitable.
  • In the past 5 years OPRA always reported a positive cash flow from operatings.
OPRA Yearly Net Income VS EBIT VS OCF VS FCFOPRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.47%, OPRA belongs to the top of the industry, outperforming 85.56% of the companies in the same industry.
  • The Return On Equity of OPRA (10.71%) is better than 76.17% of its industry peers.
  • OPRA has a better Return On Invested Capital (7.57%) than 79.06% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for OPRA is below the industry average of 10.87%.
  • The last Return On Invested Capital (7.57%) for OPRA is above the 3 year average (7.18%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.47%
ROE 10.71%
ROIC 7.57%
ROA(3y)10.76%
ROA(5y)5.96%
ROE(3y)11.99%
ROE(5y)6.66%
ROIC(3y)7.18%
ROIC(5y)N/A
OPRA Yearly ROA, ROE, ROICOPRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • OPRA has a Profit Margin of 17.62%. This is amongst the best in the industry. OPRA outperforms 83.39% of its industry peers.
  • OPRA's Profit Margin has declined in the last couple of years.
  • OPRA has a better Operating Margin (14.98%) than 82.31% of its industry peers.
  • OPRA's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 64.11%, OPRA is in line with its industry, outperforming 42.60% of the companies in the same industry.
  • OPRA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.98%
PM (TTM) 17.62%
GM 64.11%
OM growth 3Y3.33%
OM growth 5Y77.52%
PM growth 3Y57.33%
PM growth 5Y-29.54%
GM growth 3Y-8.44%
GM growth 5Y-7.62%
OPRA Yearly Profit, Operating, Gross MarginsOPRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

8

2. OPRA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OPRA is destroying value.
  • Compared to 1 year ago, OPRA has an improved debt to assets ratio.
OPRA Yearly Shares OutstandingOPRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OPRA Yearly Total Debt VS Total AssetsOPRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 7.73 indicates that OPRA is not in any danger for bankruptcy at the moment.
  • OPRA has a Altman-Z score of 7.73. This is amongst the best in the industry. OPRA outperforms 86.28% of its industry peers.
  • OPRA has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.07, OPRA belongs to the best of the industry, outperforming 81.59% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that OPRA is not too dependend on debt financing.
  • The Debt to Equity ratio of OPRA (0.00) is better than 65.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 7.73
ROIC/WACC0.85
WACC8.9%
OPRA Yearly LT Debt VS Equity VS FCFOPRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • OPRA has a Current Ratio of 2.35. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
  • OPRA's Current ratio of 2.35 is fine compared to the rest of the industry. OPRA outperforms 65.34% of its industry peers.
  • OPRA has a Quick Ratio of 2.35. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
  • OPRA has a Quick ratio of 2.35. This is in the better half of the industry: OPRA outperforms 66.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
OPRA Yearly Current Assets VS Current LiabilitesOPRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

8

3. OPRA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.49% over the past year.
  • Measured over the past years, OPRA shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.48% on average per year.
  • The Revenue has grown by 27.21% in the past year. This is a very strong growth!
  • The Revenue has been growing by 28.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16.49%
EPS 3Y67.61%
EPS 5Y22.48%
EPS Q2Q%7.14%
Revenue 1Y (TTM)27.21%
Revenue growth 3Y22.84%
Revenue growth 5Y28.32%
Sales Q2Q%21.52%

3.2 Future

  • OPRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.46% yearly.
  • The Revenue is expected to grow by 14.86% on average over the next years. This is quite good.
EPS Next Y30.11%
EPS Next 2Y22.83%
EPS Next 3Y19.8%
EPS Next 5Y20.46%
Revenue Next Year20.67%
Revenue Next 2Y18.22%
Revenue Next 3Y15.9%
Revenue Next 5Y14.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OPRA Yearly Revenue VS EstimatesOPRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
OPRA Yearly EPS VS EstimatesOPRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3

8

4. OPRA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.24, which indicates a correct valuation of OPRA.
  • Based on the Price/Earnings ratio, OPRA is valued cheaply inside the industry as 84.48% of the companies are valued more expensively.
  • OPRA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.79.
  • A Price/Forward Earnings ratio of 10.18 indicates a reasonable valuation of OPRA.
  • OPRA's Price/Forward Earnings ratio is rather cheap when compared to the industry. OPRA is cheaper than 84.84% of the companies in the same industry.
  • OPRA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.80.
Industry RankSector Rank
PE 13.24
Fwd PE 10.18
OPRA Price Earnings VS Forward Price EarningsOPRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, OPRA is valued cheaper than 87.36% of the companies in the same industry.
  • OPRA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OPRA is cheaper than 86.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.95
EV/EBITDA 10.49
OPRA Per share dataOPRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • OPRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • OPRA has a very decent profitability rating, which may justify a higher PE ratio.
  • OPRA's earnings are expected to grow with 19.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.44
PEG (5Y)0.59
EPS Next 2Y22.83%
EPS Next 3Y19.8%

5

5. OPRA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.39%, OPRA is a good candidate for dividend investing.
  • OPRA's Dividend Yield is rather good when compared to the industry average which is at 0.59. OPRA pays more dividend than 97.11% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, OPRA pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.39%

5.2 History

  • OPRA has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
OPRA Yearly Dividends per shareOPRA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • OPRA pays out 65.72% of its income as dividend. This is not a sustainable payout ratio.
DP65.72%
EPS Next 2Y22.83%
EPS Next 3Y19.8%
OPRA Yearly Income VS Free CF VS DividendOPRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M
OPRA Dividend Payout.OPRA Dividend Payout, showing the Payout Ratio.OPRA Dividend Payout.PayoutRetained Earnings

OPRA Fundamentals: All Metrics, Ratios and Statistics

OPERA LTD-ADR

NASDAQ:OPRA (3/19/2026, 4:20:54 PM)

After market: 14.96 0 (0%)

14.96

+0.34 (+2.33%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-26
Earnings (Next)04-27
Inst Owners19.15%
Inst Owner Change3.15%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.34B
Revenue(TTM)614.45M
Net Income(TTM)108.28M
Analysts83.08
Price Target25.57 (70.92%)
Short Float %7.18%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield 5.39%
Yearly Dividend0.57
Dividend Growth(5Y)N/A
DP65.72%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-07
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.94%
Min EPS beat(2)-22.87%
Max EPS beat(2)-11.01%
EPS beat(4)1
Avg EPS beat(4)-6.76%
Min EPS beat(4)-22.87%
Max EPS beat(4)8.78%
EPS beat(8)3
Avg EPS beat(8)-6.02%
EPS beat(12)6
Avg EPS beat(12)40.8%
EPS beat(16)7
Avg EPS beat(16)-5.98%
Revenue beat(2)2
Avg Revenue beat(2)2.93%
Min Revenue beat(2)0.56%
Max Revenue beat(2)5.29%
Revenue beat(4)4
Avg Revenue beat(4)3.36%
Min Revenue beat(4)0.56%
Max Revenue beat(4)6.51%
Revenue beat(8)6
Avg Revenue beat(8)2.04%
Revenue beat(12)9
Avg Revenue beat(12)1.47%
Revenue beat(16)13
Avg Revenue beat(16)2.24%
PT rev (1m)0%
PT rev (3m)-1.68%
EPS NQ rev (1m)-9.45%
EPS NQ rev (3m)3.29%
EPS NY rev (1m)-9.6%
EPS NY rev (3m)-2.05%
Revenue NQ rev (1m)7.2%
Revenue NQ rev (3m)7.01%
Revenue NY rev (1m)5.27%
Revenue NY rev (3m)4.98%
Valuation
Industry RankSector Rank
PE 13.24
Fwd PE 10.18
P/S 2.18
P/FCF 11.95
P/OCF 11.39
P/B 1.33
P/tB 2.79
EV/EBITDA 10.49
EPS(TTM)1.13
EY7.55%
EPS(NY)1.47
Fwd EY9.83%
FCF(TTM)1.25
FCFY8.36%
OCF(TTM)1.31
OCFY8.78%
SpS6.85
BVpS11.27
TBVpS5.37
PEG (NY)0.44
PEG (5Y)0.59
Graham Number16.93
Profitability
Industry RankSector Rank
ROA 9.47%
ROE 10.71%
ROCE 8.98%
ROIC 7.57%
ROICexc 8.92%
ROICexgc 22.82%
OM 14.98%
PM (TTM) 17.62%
GM 64.11%
FCFM 18.26%
ROA(3y)10.76%
ROA(5y)5.96%
ROE(3y)11.99%
ROE(5y)6.66%
ROIC(3y)7.18%
ROIC(5y)N/A
ROICexc(3y)8.27%
ROICexc(5y)N/A
ROICexgc(3y)22.13%
ROICexgc(5y)N/A
ROCE(3y)8.52%
ROCE(5y)N/A
ROICexgc growth 3Y14.94%
ROICexgc growth 5Y134.47%
ROICexc growth 3Y22.52%
ROICexc growth 5Y130.89%
OM growth 3Y3.33%
OM growth 5Y77.52%
PM growth 3Y57.33%
PM growth 5Y-29.54%
GM growth 3Y-8.44%
GM growth 5Y-7.62%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA 0.04
Cap/Depr 29.4%
Cap/Sales 0.9%
Interest Coverage 150.85
Cash Conversion 106.18%
Profit Quality 103.6%
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 7.73
F-Score7
WACC8.9%
ROIC/WACC0.85
Cap/Depr(3y)65.11%
Cap/Depr(5y)44.73%
Cap/Sales(3y)2.09%
Cap/Sales(5y)1.53%
Profit Quality(3y)85.76%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.49%
EPS 3Y67.61%
EPS 5Y22.48%
EPS Q2Q%7.14%
EPS Next Y30.11%
EPS Next 2Y22.83%
EPS Next 3Y19.8%
EPS Next 5Y20.46%
Revenue 1Y (TTM)27.21%
Revenue growth 3Y22.84%
Revenue growth 5Y28.32%
Sales Q2Q%21.52%
Revenue Next Year20.67%
Revenue Next 2Y18.22%
Revenue Next 3Y15.9%
Revenue Next 5Y14.86%
EBIT growth 1Y-0.39%
EBIT growth 3Y26.93%
EBIT growth 5Y127.8%
EBIT Next Year88.94%
EBIT Next 3Y36.85%
EBIT Next 5Y28.05%
FCF growth 1Y37.42%
FCF growth 3Y28.02%
FCF growth 5Y4.84%
OCF growth 1Y12.15%
OCF growth 3Y27.61%
OCF growth 5Y4.76%

OPERA LTD-ADR / OPRA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of OPERA LTD-ADR (OPRA) stock?

ChartMill assigns a fundamental rating of 8 / 10 to OPRA.


What is the valuation status of OPERA LTD-ADR (OPRA) stock?

ChartMill assigns a valuation rating of 8 / 10 to OPERA LTD-ADR (OPRA). This can be considered as Undervalued.


Can you provide the profitability details for OPERA LTD-ADR?

OPERA LTD-ADR (OPRA) has a profitability rating of 7 / 10.


How financially healthy is OPERA LTD-ADR?

The financial health rating of OPERA LTD-ADR (OPRA) is 8 / 10.


What is the earnings growth outlook for OPERA LTD-ADR?

The Earnings per Share (EPS) of OPERA LTD-ADR (OPRA) is expected to grow by 30.11% in the next year.